Intravascular cell-to-cell adhesive interactions and bone metastasis

Cancer and Metastasis Reviews

Volumn 25, Issue 4, 2006, Pages 531-540

  Glinsky, Vladislav V ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

Author keywords

Adhesion; Bone metastasis; CD44; CXCR4; Endothelium; Galectin 3; SDF 1; Thomsen Friedenreich antigen

Indexed keywords

CELL ADHESION MOLECULE;

BONE MARROW CELL; BONE METASTASIS; CANCER CELL; CELL ADHESION; CELL AGGREGATION; CELL INTERACTION; CIRCULATION; ENDOTHELIUM; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; BONE MARROW CELLS; BONE NEOPLASMS; CELL ADHESION; CELL ADHESION MOLECULES; ENDOTHELIUM; HUMANS;

EID: 33846083869     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-006-9029-8     Document Type: Review

References (99)

1. Rubens, R. D. (1998). Bone metastases - the clinical problem. European Journal of Cancer, 34, 210-213.
2. Rubens, R. D., & Mundy, G. R. (2000). Cancer and the skeleton. London: Martin Dunitz.
3. Rubin, M. A., Pitzi, M., Mucci, N., Smith, D. C., Wojno, K., Korenchuk, S., et al. (2000). Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clinical Cancer Research, 6, 1038-1045.
4. Loberg, R. D., Gayed, B. A., Olson, K. B., & Pienta, K. J. (2005). A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions. Journal of Cellular Biochemistry, 96, 439-446.
5. Loberg, R. D., Logothetis, C. J., Keller, E. T., & Pienta, K. J. (2005). Pathogenesis and treatment of prostate cancer bone metastases: Targeting the lethal phenotype. Journal of Clinical Oncolology, 23, 8232-8241.
6. Tantivejkul, K., Kalikin, L. M., & Pienta, K. J. (2004). Dynamic process of prostate cancer metastasis to bone. Journal of Cellular Biochemistry, 91, 706-717.
7. Chambers, A. F., Naumov, G. N., Vantyghem, S. A., & Tuck, A. B. (2000). Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Research, 2, 400-407.
8. Kim, H. R., Lin, H. M., Biliran, H., & Raz, A. (1999). Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Research, 59, 4148-4154.
9. Zhu, Z., Sanchez-Sweatman, O., Huang, X., Wiltrout, R., Khokha, R., Zhao, Q., et al. (2001). Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Research, 61, 1707-1716.
10. Nakahara, S., Oka, N., & Raz, A. (2005). On the role of galectin-3 in cancer apoptosis. Apoptosis, 10, 267-275.
11. Walz, D. A., & Fenton, J. W. (1994). The role of thrombin in tumor cell metastasis. Invasion & Metastasis, 14, 303-308.
12. Karpatkin, S., Pearlstein, E., Ambrogio, C., & Coller, B. S. (1988). Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. The Journal of Clinical Investigation, 81, 1012-1019.
13. Meromsky, L., Lotan, R., & Raz, A. (1986). Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. Cancer Research, 46, 5270-5275.
14. Updyke, T. V., & Nicolson, G. L. (1986). Malignant melanoma cell lines selected in vitro for increased homotypic adhesion properties have increased experimental metastatic potential. Clinical & Experimental Metastasis, 4, 273-284.
15. Lotan, R., & Raz, A. (1988). Endogenous lectins as mediators of tumor cell adhesion. Journal of Cellular Biochemistry, 37, 107-117.
16. Glinsky, V. V., Glinsky, G. V., Glinskii, O. V., Huxley, V. H., Turk, J. R., Mossine, V. V., et al. (2003). Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Research, 63, 3805-3811.
17. Cooper, C. R., Chay, C. H., Gendernalik, J. D., Lee, H. L., Bhatia, J., Taichman, R. S., et al. (2003). Stromal factors involved in prostate carcinoma metastasis to bone. Cancer, 97, 739-747.
18. Trikha, M., & Nakada, M. T. (2002). Platelets and cancer: Implications for antiangiogenic therapy. Semininars in Thrombosis and Hemostasis, 28, 39-44.
19. Chay, C. H., Cooper, C. R., Gendernalik, J. D., Dhanasekaran, S. M., Chinnaiyan, A. M., Rubin, M. A., et al. (2002). A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines. Urology, 60, 760-765.
20. Kato, Y., Fujita, N., Kunita, A., Sato, S., Kaneko, M., Osawa, M., et al. (2003). Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors. The Journal of Biological Chemistry, 278, 51599-51605.
21. Im, J. H., Fu, W., Wang, H., Bhatia, S. K., Hammer, D. A., Kowalska, M. A., et al. (2004). Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Research, 64, 8613-8619.
22. Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001). Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinomamucins, and tumor metastasis. Proceedings of the National Academy of Science of the United States of America, 98, 3352-3357.
23. Stoelcker, B., Hafner, M., Orosz, P., Nieswandt, B., & Mannel, D. N. (1996). Role of adhesion molecules and platelets in TNFinduced adhesion of tumor cells to endothelial cells: implications for experimental metastasis. Journal of Inflammation, 46, 155-167.
24. Trikha, M., Raso, E., Cai, Y., Fazakas, Z., Paku, S., Porter, A. T., et al. (1998). Role of αII(b)β3 integrin in prostate cancer metastasis. Prostate, 35, 185-192.
25. Saiki, I., Naito, S., Yoneda, J., Azuma, I., Price, J. E., & Fidler, I. J. (1991). Characterization of the invasive and metastatic phenotype in human renal cell carcinoma. Clinical & Experimental Metastasis, 9, 551-566.
26. Glinsky, G. V., & Glinsky, V. V. (1996). Apoptosis and metastasis: A superior resistance of metastatic cancer cells to programmed cell death. Cancer Letters, 101, 43-51.
27. Glinsky, G. V., Glinsky, V. V., Ivanova, A. B., & Hueser, C. N. (1997). Apoptosis and metastasis: Increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Letters, 115, 185-193.
28. Fidler, I. J. (1975). The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. European Journal of Cancer, 9, 223-227.
29. Khaldoyanidi, S. K., Glinsky, V. V., Sikora, L., Glinskii, A. B., Mossine, V. V., Quinn, T. P., et al. (2003). MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. The Journal of Biological Chemistry, 278, 4127-4134.
30. Orr, F. W., & Wang, H. H. (2001). Tumor cell interactions with the microvasculature: A rate-limiting step in metastasis. Surgicol Oncology Clinics of North America, 10, 357-381.
31. Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer, 2, 563-572.
32. Fidler, I. (2003). The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nature Reviews Cancer, 3, 453-458.
33. Glinskii, O. V., Huxley, V. H., Glinsky, G. V., Pienta, K. J., Raz, A., & Glinsky, V. V. (2005). Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia, 7, 522-527.
34. Lehr, J. E., & Pienta, K. J. (1998). Prefential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. Journal of the National Cancer Institute, 90, 118-123.
35. Scott, L. J., Clarke, N. W., George, N. J. R., Shanks, J. H., Testa, N. G., & Lang, S. H. (2001). Interactions of human prostatic epithelial cells with bone marrow endothelium: Binding and invasion. British Journal of Cancer, 84, 1417-1423.
36. Glinsky, V. V., Glinsky, G. V., Rittenhouse-Olsen, K., Huflejt, M. E., Glinskii, O. V., Deutscher, S. L., et al. (2001). The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Research, 61, 4851-4857.
37. Glinsky, V. V., Huflejt, M. E., Glinsky, G. V., Deutscher, S. L., & Quinn, T. P. (2000). Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Research, 60, 2584-2588.
38. Honn, K. V., & Tang, D. G. (1992). Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Review, 11, 353-375.
39. Cooper, C. R., Sikes, R. A., Nicholson, B. E., Sun, Y. X., Pienta, K. J., & Taichman, R. S. (2004). Cancer cells homing to bone: The significance of chemotaxis and cell adhesion. Cancer Treatment and Research, 118, 291-309.
40. McEver, R. P. (1997). Selectin-carbohydrate interactions during inflammation andmetastasis. Glycoconjugate Journal, 14, 585-591.
41. Butcher, E. C. (1991). Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell, 67 1033-1036.
42. Lawrence, M. B., & Springer, T. A. (1991). Leukocytes roll on selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell, 65, 859-873.
43. Krause, T., & Turner, G. A. (1999). Are selectins involved in cancer metastasis? Clinical & Experimental Metastasis, 17, 183-192.
44. Cooper, C. R., Bhatia, J. K., Muenchen, H. J., McLean, L., Hayasaka, S., Taylor, J., et al. (2002). The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clinical & Experimental Metastasis, 19, 25-33.
45. Glinskii, O. V., Turk, J. R., Pienta, K. J., Huxley, V. H., & Glinsky, V. V. (2004). Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells. Journal of Physiology, 554, 89-99.
46. Dimitroff, C. J., Lechpammer, M., Long-Woodward, D., & Kutok, J. L. (2004). Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Research, 64, 5261-5269.
47. Dimitroff, C. J., Descheny, L., Trujillo, N., Kim, R., Nguyen, V., Huang, W., et al. (2005). Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Research, 65, 5750-5760.
48. Satoh, M., Numahata, K., Kawamura, S., Saito, S., & Orikasa, S. (1998). Lack of selectin-dependent adhesion in prostate cancer cells expressing sialyl Le(x). International Journal of Urology, 5, 86-91.
49. Cooper, C. R., McLean, L., Mucci, N. R., Poncza, P., & Pienta, K. J. (2000). Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by beta-1 integrin subunit. Anticancer Research, 20, 4159-4162.
50. Romanov, V. I., & Goligorsky, M. S. (1999). RGD-recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro. Prostate, 39, 108-118.
51. Wang, H., Fu, W., Im, J. H., Zhou, Z., Santoro, S. A., Iyer, V., et al. (2004). Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. The Journal of Cell Biology, 164, 935-941.
52. Nangia-Makker, P., Hogan, V., Honjo, Y., Baccarini, S., Tait, L., Bresalier, R., et al. (2002). Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. Journal of the National Cancer Institute, 94, 1854-1862.
53. Zou, J., Glinsky, V. V., Landon, L. A., Matthews, L., Deutscher, S. L. (2005). Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis, 26, 309-18.
54. Nangia-Makker, P., Sarvis, R., Visscher, D. W., Baily-Penrod, J., Raz, A., & Sarkar, F. H. (1998). Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Research and Treatment, 49, 171-183.
55. Honjo, Y., Nangia-Makker, P., Inohara, H., & Raz, A. (2001). Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clinical Cancer Research, 7, 661-668.
56. Kim, H. R., Lin, H. M., Biliran, H., & Raz, A. (1999). Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Research, 59, 4148-4154.
57. Matarrese, P., Fusco, O., Tinari, N., Natoli, C., Liu, F. T., Semeraro, M. L., et al. (2000). Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. International Journal of Cancer, 85, 545-554.
58. Moon, B. K., Lee, Y. J., Battle, P., Jessup, J. M., Raz, A., & Kim, H. R. (2001). Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: Implication of galectin-3 function during metastasis. The American Journal of Pathology, 159, 1055-1060.
59. Fukumori, T., Oka, N., Takenaka, Y., Nangia-Makker, P., Elsamman, E., Kasai, T., et al. (2006). Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Research, 66, 3114-3119.
60. Nakahara, S., Oka, N., & Raz, A. (2005). On the role of galectin-3 in cancer apoptosis. Apoptosis, 10, 267-275.
61. Inohara, H., & Raz, A. (1994). Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconjugate Journal, 11, 527-532.
62. Shimura, T., Takenaka, Y., Fukumori, T., Tsutsumi, S., Okada, K., Hogan, V., et al. (2005). Implication of galectin-3 in Wnt signaling. Cancer Research, 65, 3535-3537.
63. Shimura, T., Takenaka, Y., Tsutsumi, S., Hogan, V., Kikuchi, A., & Raz, A. (2004). Galectin-3, a novel binding partner of beta-catenin. Cancer Research, 64, 6363-6367.
64. Shalom-Feuerstein, R., Cooks, T., Raz, A., & Kloog, Y. (2005). Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells. Cancer Research, 65, 7292-7300.
65. Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K. J., et al. (2000). Galectin-3 induces endothelial cell morphogenesis and angiogenesis. The American Journal of Pathology, 156, 899-909.
66. Fukushi, J., Makagiansar, I. T., & Stallcup, W. B. (2004). NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Molecular Biology of the Cell, 15, 3580-3590.
67. Springer, G. F., Desai, P. R., Ghazizadeh, M., & Tegtmeyer, H. (1995). T/Tn pancarcinoma autoantigens: Fundamental, diagnostic, and prognostic aspects. Cancer Detection and Prevention, 19, 173-182.
68. Lotan, R., Belloni, P. N., Tressler, R. J., Lotan, D., Xu, X. C., & Nicolson, G. L. (1994). Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconjugate Journal, 11, 462-468.
69. Pienta, K. J., Naik, H., Akhtar, A., Yamazaki, K., Replogle, T. S., Lehr, J., et al. (1995). Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. Journal of the National Cancer Institute, 87, 348-353.
70. Glinsky, G. V., Price, J. E., Glinsky, V. V., Mossine, V. V., Kiriakova, G., & Metcalf, J. B. (1996). Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Cancer Research, 56, 5319-5324.
71. Ponta, H., Sherman, L., & Herrlich, P. A. (2003). CD44: From adhesion molecules to signalling regulators. Nature Reviews. Molecular Cell Biology 4, 33-45.
72. Okado, T., & Hawley, R. G. (1995). Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements. International Journal of Cancer, 63, 823-830.
73. Mine, S., Fujisaki, T., Kawahara, C., Tabata, T., Iida, T., Yasuda, M., et al. (2003). Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44. Experimental Cell Research, 288, 189-197.
74. Hill, A., McFarlane, S., Mulligan, K., Gillespie, H., Draffin, J. E., Trimble, A., et al. (2006). Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene, 25, 6079-6091.
75. Draffin, J. E., McFarlane, S., Hill, A., Johnston, P. G., & Waugh, D. J. J. (2004). CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Research, 64, 5702-5711.
76. Hill, A., McFarlane, S., Johnston, P. G., & Waugh, D. J. (2006). The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Letter, 237, 1-9.
77. Simpson, M. A., Reiland, J., Burger, S. R., Furcht, L. T., Spicer, A. P., Oegema, T. R., Jr, et al. (2001). Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells. The Journal of Biological Chemistry, 276, 17949-17957.
78. Simpson, M. A., Wilson, C. M., Furcht, L. T., Spicer, A. P., Oegema, T. R., Jr, & McCarthy, J. B. (2002). Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. The Journal of Biological Chemistry, 277, 10050-10057.
79. Simpson, M. A., Wilson, C. M., & McCarthy, J. B. (2002). Inhibition of prostate tumour cell hyaluronan synthesis impairs subcutaneous growth and vascularisation in immunocompromised mice. The American Journal of Pathology, 161, 849-857.
80. Singh, R., Campbell, B. J., Yu, L. G., Fernig, D. G., Milton, J. D., & Goodlad, R. A. (2001). Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology, 11, 587-592.
81. Avigdor, A., Goichberg, P., Shivtiel, S., Dar, A., Peled, A., Samira, S., et al. (2004). CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood, 103, 2981-2989.
82. Lapidot, T., Dar, A., & Kollet, O. (2005). How do stem cells find their way home? Blood, 106, 1901-1910.
83. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., et al. (2005). Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis. Stem Cells, 23, 879-894.
84. Neiva, K., Sun, Y. X., & Taichman, R. S. (2005). The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis. Brazilian Journal of Medical and Biology Research, 38, 1449-1454.
85. Zlotnik, A. (2006). Involvement of chemokine receptors in organ-specific metastasis. Contributions to Microbiology, 13, 191-199.
86. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
87. Taichman, R. S., Cooper, C., Keller, E. T, Pienta, K. J., Taichman, N. S., & McCauley, L. K. (2002). Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research, 62, 1832-1837.
88. Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., & Ben-Baruch, A. (2001). A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. The Journal of Immunology, 167, 4747-4757.
89. Libura, J., Drukala, J., Majka, M., Tomescu, O., Navenot, J. M., Kucia, M., et al. (2002). CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood, 100, 2597-2606.
90. Sloan, E. K., & Anderson, R. L. (2002). Genes involved in breast cancer metastasis to bone. Cellular and Molecular Life Sciences, 59, 1491-1502.
91. Jankowski, K., Kucia, M., Wysoczynski, M., Reca, R., Zhao, D., Trzyna, E., et al. (2003). Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Research, 63, 7926-7935.
92. Prasad, A., Fernandis, A. Z., Rao, Y., & Ganju, R. K. (2004). Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. The Journal of Biological Chemistry, 279, 9115-9124.
93. Gazitt, Y., & Akay, C. (2004). Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4. Stem Cells, 22, 65-73.
94. Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Cote, D., Means, T. K., et al. (2005). In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature, 435, 969-973.
95. Havens, A. M., Jung, Y., Sun, Y. X., & Taichman, R. S. (2006). The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer, 6, 195; doi: http://dx.doi.org/10.1186/1471-2407-6-195.
96. Masuzawa, Y., Miyauchi, T., Hamanoue, M., Ando, S., Yoshida, J., Takao, S., et al. (1992). A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells: sequence analysis and examination of gene expression. Journal of Biochemistry (Tokyo), 112, 609-615.
97. Chan, J. Y., Lee-Prudhoe, J. E., Jorgensen, B., Ihrke, G., Doyonnas, R., Zannettino, A. C., et al. (2001). Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn. The Journal of Biological Chemistry, 276, 2139-2152.
98. Sun, Y. X., Schneider, A., Jung, Y., Wang, J., Dai, J., Wang, J., et al. (2005). Skeletal localization and neutralization of the SDF-1 (CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. Journal of Bone and Mineral Research, 20, 318-329.
99. Al-Mehdi, A. B., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., & Muschel, R. J. (2000). Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis. Nature Medicine, 6, 100-102.